Best for
Mobile
How to buy Verona Pharma shares | 25.85p
Own Verona Pharma shares in just a few minutes.
Verona Pharma plc is a biotechnology business based in the UK. Verona Pharma shares (VRP.LSE) are listed on the London Stock Exchange (LSE) and all prices are listed in pence sterling. Its last market close was 25.85p – an increase of 0.19% over the previous week. Verona Pharma employs 33 staff and has a market cap (total outstanding shares value) of £228 million.
How to buy shares in Verona Pharma
- Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: VRP in this case.
- Research Verona Pharma shares. The platform should provide the latest information available.
- Buy your Verona Pharma shares. It's that simple.
What's in this guide?
- Can I buy shares in Verona Pharma?
- Has coronavirus impacted Verona Pharma shares?
- Verona Pharma shares summary
- Compare share dealing platforms
- Is Verona Pharma stock a buy or sell?
- Verona Pharma's financials
- How volatile are Verona Pharma shares?
- Does Verona Pharma pay a dividend?
- Have Verona Pharma shares ever split?
- Other common questions
How has Coronavirus impacted Verona Pharma's share price?
Since the stock market crash in March caused by coronavirus, Verona Pharma's share price has had significant negative movement.
Its last market close was 25.85p, which is 60.20% down on its pre-crash value of 64.95p and 10.64% down on the lowest point reached during the March crash when the shares fell as low as 28.6p.
If you had bought £1,000 worth of Verona Pharma shares at the start of February 2020, those shares would have been worth £670.10 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth £532.99.
Verona Pharma share price
Use our graph to track the performance of VRP stocks over time.Verona Pharma shares at a glance
Information last updated 2020-12-27.
| Latest market close | 25.85p |
|---|---|
| 52-week range | 13.33p - 26.46p |
| 50-day moving average | 55p |
| 200-day moving average | 62.902p |
| Wall St. target price | 247.67p |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | -18.7p |
Invest in Verona Pharma shares with 0% commission
Other fees may apply. Your capital is at risk.
- Unlimited trades, with no dealing charges or management fees
- If your trades get copied you can earn extra money
- Create an account today in a few minutes
Go to site
Capital at risk
Share dealing platform comparison
Table: sorted by promoted deals first
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Is it a good time to buy Verona Pharma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Verona Pharma financials
| Gross profit TTM | £0 |
|---|---|
| Return on assets TTM | -45.08% |
| Return on equity TTM | 0% |
| Profit margin | 0% |
| Book value | 0.18p |
| Market capitalisation | £228 million |
TTM: trailing 12 months
Verona Pharma share dividends
We're not expecting Verona Pharma to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Have Verona Pharma's shares ever split?
Verona Pharma's shares were split on a 1:50 basis on 13 February 2017. So if you had owned 50 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Verona Pharma shares – just the quantity. However, indirectly, the new 4900% higher share price could have impacted the market appetite for Verona Pharma shares which in turn could have impacted Verona Pharma's share price.
Verona Pharma share price volatility
Over the last 12 months, Verona Pharma's shares have ranged in value from as little as 13.33p up to 26.46p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Verona Pharma's is -0.4932. This would suggest that Verona Pharma's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Verona Pharma has bucked the trend.
Win £500 to get your trading started
Subscribe to trending stock alerts for a chance to win
Verona Pharma overview
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on develops and commercializes therapies for the treatment of respiratory diseases with unmet medical needs. Its product candidate, ensifentrine (RPL554), is an inhaled, dual inhibitor of the enzymes phosphodiesterase 3 and 4 that acts as both a bronchodilator and an anti-inflammatory agent in a single compound. The formulations of ensifentrine are under development for the treatment chronic obstructive pulmonary disease (COPD): nebulized ensifentrine is in Phase 2b clinical development for the maintenance treatment of COPD; and a dry powder inhaler and a pressurized metered-dose inhaler. The company also focuses on developing ensifentrine for the treatment of cystic fibrosis and asthma. Verona Pharma plc was founded in 2005 and is headquartered in London, the United Kingdom.
Frequently asked questions
More guides on Finder
-
How to buy Verona Pharma shares
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Charlie’s Holdings shares
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Lemonade shares | $50.05
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Unity Software shares | $111.51
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
-
How to buy FuelCell Energy shares | $3.745
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Verona Pharma shares | $0.1275
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
-
How to buy Zomedica Pharmaceuticals shares | $0.93
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
-
How to buy YRC Worldwide shares | $4.66
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
-
How to buy Xeros Technology Group shares | 220p
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
-
How to buy Xpediator shares | 33.5p
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
Ask an Expert